Our studies have also shown that IL-33 is upregulated in the glia of neurodegenerative diseases such as in Alzheimer’s disease brain [45], and MPP+ induced IL-33 release from mouse astrocytes in vitro [68]. This evidence concerns the gene IL33 and neurodegenerative disease.